Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Antozyme Biotech is a private Indian biotechnology company focused on the development, manufacture, formulation, and export of industrial enzymes. The company supplies enzyme products for multiple end markets including pharmaceuticals, food and beverage, starch processing, distillery, brewery, textiles, detergents, agriculture, wastewater treatment, and nutraceutical-related applications. Antozyme appears to operate as a commercial-stage manufacturer rather than a therapeutics developer, with capabilities spanning R&D, microbial fermentation, downstream processing, custom enzyme blends, and formulation in powder, liquid, and granular formats. Its product portfolio includes core enzyme classes such as proteases, amylases, cellulases, lipases, lactase, laccase, transglutaminase, bromelain, papain, and related specialty enzymes. The company markets itself as an export-oriented enzyme supplier serving customers in India and more than 34 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Antozyme Biotech.